These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1105219)

  • 1. Blood viscosity factors and occlusive arterial disease in renal transplant recipients.
    Dintenfass L; Ibels LS
    Nephron; 1975; 15(6):456-65. PubMed ID: 1105219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood rheology in occlusive arterial disease following successful cadaveric kidney transplantation.
    Dintenfass L; Ibels LS
    Biorheology; 1976 Feb; 13(1):27-32. PubMed ID: 779864
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered flow properties of blood and increased plasma fibrinogen in cyclosporin-treated renal allograft recipients.
    Linde T; Sandhagen B; Backman U; Fellström B
    Nephrol Dial Transplant; 1999 Jun; 14(6):1525-9. PubMed ID: 10383019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.
    Ibels LS; Stewart JH; Mahony JF; Neale FC; Sheil AG
    Q J Med; 1977 Apr; 46(182):197-214. PubMed ID: 325593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deaths from occlusive arterial disease in renal allograft recipients.
    Ibels LS; Stewart JH; Mahony JF; Sheil AG
    Br Med J; 1974 Aug; 3(5930):552-4. PubMed ID: 4606408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrheological variables in critical limb ischemia.
    Köksal C; Ercan M; Bozkurt AK
    Int Angiol; 2002 Dec; 21(4):355-9. PubMed ID: 12518116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease.
    Di Perri T; Forconi S; Agnusdei D; Guerrini M; Laghi Pasini F
    Br J Clin Pharmacol; 1978 Mar; 5(3):255-60. PubMed ID: 656271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on haematocrit in peripheral arterial disease.
    Lowe GD; Saniabadi A; Turner A; Lieberman P; Pollock J; Drury J
    Klin Wochenschr; 1986 Oct; 64(19):969-74. PubMed ID: 3784449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.
    Poredos P; Zizek B
    Angiology; 1996 Mar; 47(3):253-9. PubMed ID: 8638868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial and venous blood viscosity in ischemic lower limbs in patients affected by peripheral obliterative arterial disease.
    Forconi S; Guerrini M; Ravelli P; Rossi C; Ferrozzi C; Pecchi S; Biasi G
    J Cardiovasc Surg (Torino); 1979; 20(4):379-84. PubMed ID: 479273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels with cigarette smokers.
    Dintenfass L
    Med J Aust; 1975 May; 1(20):617-20. PubMed ID: 1143159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
    van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
    Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise fitness, cardiac work and blood viscosity factors in patients and normals.
    Dintenfass L; Lake B
    Eur Surg Res; 1976; 8(2):174-84. PubMed ID: 954781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
    Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Grzegorczyn S
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):700-3. PubMed ID: 1669136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality.
    Jonason T; Bergström R
    Acta Med Scand; 1987; 221(3):253-60. PubMed ID: 3591463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
    Dintenfass L; Stewart JH; Milton GW; Forbes CD
    Biorheology; 1973 Dec; 10(4):585-94. PubMed ID: 4593440
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinogen and mechanisms of thrombosis. A difficult link.
    Di Minno G; Cerbone A; Margaglione M; Vecchione G; Grandone E; Mancini M
    Eur J Epidemiol; 1992 May; 8 Suppl 1():88-91. PubMed ID: 1505658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet drugs in arterial thrombosis: a review.
    Tsu EC
    Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.